Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Abstract Text:

Carolyn M Dresler,Jemi Olak,James E Herndon,William G Richards,Ernest Scalzetti,Stewart B Fleishman,Kemp H Kernstine,Todd Demmy,David M Jablons,Leslie Kohman,Thomas M Daniel,George B Haasler,David J Sugarbaker, , , , ,

STUDY OBJECTIVE: To demonstrate the efficacy, safety, and appropriate mode of instillation of talc for sclerosis in treatment of malignant pleural effusions (MPEs). DESIGN: A prospective, randomized trial was designed to compare thoracoscopy with talc insufflation (TTI) to thoracostomy and talc slurry (TS) for patients with documented MPE. MEASUREMENTS: The primary end point was 30-day freedom from radiographic MPE recurrence among surviving patients whose lungs initially re-expanded > 90%. Morbidity, mortality, and quality of life were also assessed. RESULTS: Of 501 patients registered, those eligible were randomized to TTI (n = 242) or TS (n = 240). Patient demographics and primary malignancies were similar between study arms. Overall, there was no difference between study arms in the percentage of patients with successful 30-day outcomes (TTI, 78%; TS, 71%). However, the subgroup of patients with primary lung or breast cancer had higher success with TTI than with TS (82% vs 67%). Common morbidity included fever, dyspnea, and pain. Treatment-related mortality occurred in nine TTI patients and seven TS patients. Respiratory complications were more common following TTI than TS (14% vs 6%). Respiratory failure was observed in 4% of TS patients and 8% of TTI patients, accounting for five toxic deaths and six toxic deaths, respectively. Quality-of-life measurement demonstrated less fatigue with TTI than TS. Patient ratings of comfort and safety were also higher for TTI, but there were no differences on perceived value or convenience of the procedures. CONCLUSIONS: Both methods of talc delivery are similar in efficacy; TTI may be better for patients with either a lung or breast primary. The etiology and incidence of respiratory complications from talc need further exploration.

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Publishing Authors By Initials

CM Dresler,J Olak,JE Herndon,WG Richards,E Scalzetti,SB Fleishman,KH Kernstine,T Demmy,DM Jablons,L Kohman,TM Daniel,GB Haasler,DJ Sugarbaker, , , , ,

For similar surgical procedures, operative: ostomy: thoracostomy research abstracts see: surgical procedures, operative: ostomy: thoracostomy research

PUBMED ID PMID:

MEDLINE DATE:

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Chest

VOLUME: 127

Page Numbers: 909-15

Journal Abbreviation: Chest

ISSN: 0012-3692

DAY: 7

MONTH: Mar

YEAR: 2005

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 231335

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Keywords Mesh Terms:

KEYWORDS: Thoracostomy

MESH TERMS: administration & dosage

Chemical & Substance for Abstract: Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Information

Substance Name: Talc

Registry Number: 14807-96-6

Grant and Affiliation Information for Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

AFFILIATION: Head, Tobacco Unit, International Agency for Research on Cancer, Lyon, France. Carolyn_dresler@ksg03.harvard.edu

Country: United States

AGENCY: United States NCI

GRANT: R01 CA093708-01A3

ACRONYM: CA

MEDLINETA: Chest

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion Related Publications

• A critical analysis of recent methods of treatment of thromboembolic disease.
• Building on a consensus.
• Carcinoma of the breast.
• Carcinoma of the colon and rectum.
• Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
• Compartment syndrome of the leg associated with lithotomy position for cytoreductive surgery.
• Complications of extrapleural pneumonectomy.
• Cytoreduction of the small bowel surfaces.
• Discordant histology of primary appendiceal adenocarcinoid neoplasms with peritoneal dissemination.
• Intraperitoneal chemotherapy and immunotherapy.
• Is repeated hepatic resection justified for malignancy?
• Local-regional approach to diffuse malignant peritoneal mesothelioma.
• Mediastinal emphysema and bilateral pneumothorax complicating operations on the neck.
• Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
• Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.
• Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
• Rectus abdominis muscle resection for abdominal wall recurrence of mucinous adenocarcinoma or peritoneal mesothelioma.
• Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
• So03 critical analysis of treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
• So13p cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma - analysis of 100 consecutive patients from a prospective database.
• So14p perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
• Surgical interventions for emphysema.
• Surgical management of cancer patients.
• Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer.
• The organ selectivity of experimentally induced metastases in rats.
• Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
• Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study.